Loading…
Supreme Rejuvenation, LLC was cited for marketing unapproved new drugs and unlicensed biological products, specifically stem cell-derived exosomes sold through their website and Instagram without required FDA approval under the Federal Food, Drug, and Cosmetic Act and Public Health Service Act. The company marketed products including "100 Billion Exosomes: Human Umbilical Cord Mesenchymal Stem Cell Derived Exosomes" and various exosome gels for allogeneic use with claims intended to diagnose, cure, mitigate, treat, or prevent disease or affect body structure and function. The Center for Biologics Evaluation and Research determined that these products were introduced into interstate commerce without the required approved biologics license application (BLA) or new drug application, violating federal law.